PAVmed (PAVM) Short term Debt (2018 - 2025)

PAVmed has reported Short term Debt for 7 years, with the latest figure at $11.1 million in Q4 2025.

• For the quarter ending Q4 2025, Short term Debt fell 61.86% year-over-year to $11.1 million; the trailing twelve-month figure through Dec 2025 stood at $11.1 million (down 61.86% YoY), and the FY2025 full-year result was $11.1 million, down 61.86% from the prior year.
• Short term Debt for Q4 2025 stood at $11.1 million, up from $6.9 million in the prior quarter.
• The five-year high for Short term Debt was $45.5 million in Q1 2024, with the low at $260000.0 in Q2 2023.
• Average Short term Debt over 4 years is $26.2 million, with a median of $29.5 million recorded in 2022.
• Year-over-year, Short term Debt plunged 99.12% in 2023 and surged 16823.08% in 2024.
• Tracing PAVM's Short term Debt over 4 years: stood at $33.6 million in 2022, then soared by 31.35% to $44.2 million in 2023, then sank by 34.16% to $29.1 million in 2024, then sank by 61.86% to $11.1 million in 2025.
• The last three Short term Debt figures came in at $11.1 million (Q4 2025), $6.9 million (Q3 2025), and $6.8 million (Q2 2025), per Business Quant data.

Peer Comparison